Array BioPharma (ARRY) PT Raised to $35 at Piper Jaffray
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $5.17 -0.39%
Rating Summary:
18 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
18 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Piper Jaffray analyst Edward Tenthoff raised the price target on Array BioPharma (NASDAQ: ARRY) to $35.00 (from $28.00) while maintaining a Overweight rating.
- BEACON Interim Analysis Hits, sNDA Filing in 2H:19
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Deutsche Bank Upgrades AutoStore Holdings Ltd (AUTO:NO) to Buy
- Clariant AG (CLN:SW) (CLZNY) PT Raised to CHF13 at JPMorgan
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Piper Jaffray, Edward TenthoffSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
